Niki BioSolutions, Inc. (NIKI) Notes Payables (2019 - 2022)
Niki BioSolutions' (NIKI) quarterly Notes Payables came in at $500000.0 in Q4 2022, up 4290.2% YoY from $11389.0 in Q4 2021, and up 1086856.52% on a QoQ basis from $46.0 in Q2 2022.
Niki BioSolutions, Inc. (NIKI) Notes Payables (2019 - 2022) Analysis & Trends
Niki BioSolutions (NIKI) has 4 years of Notes Payables data on file, last reported at $500000.0 in Q4 2022.
- Quarterly Notes Payables rose 4290.2% year-over-year to $500000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $500000.0 (up 4290.2% YoY) and the FY2025 annual result came in at $306000.0, up 2502.93% from the prior year.
- Notes Payables climbed to $500000.0 in Q4 2022, from $46.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $3629.4 billion in Q2 2020 to a low of $46.0 in Q2 2022.
- A 4-year average of $453.7 billion and a median of $1.6 million in 2020 frame the typical range for Notes Payables.
- The widest YoY moves for Notes Payables: up 4290.2% in 2022, down 100.0% in 2022.
- Tracing NIKI's Notes Payables over 4 years: stood at $6.3 million in 2019, then slumped by 68.29% to $2.0 million in 2020, then tumbled by 99.43% to $11389.0 in 2021, then jumped by 4290.2% to $500000.0 in 2022.
- The last three Notes Payables figures came in at $500000.0 (Q4 2022), $46.0 (Q2 2022), and $11389.0 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 500,000.00 |
| Jun 30, 2022 | 46.00 |
| Dec 31, 2021 | 11,389.00 |
| Jun 30, 2021 | 1.10 Mn |
| Dec 31, 2020 | 2.01 Mn |
| Jun 30, 2020 | 2.31 Mn |
| Apr 30, 2020 | 3,629.35 Bn |
| Dec 31, 2019 | 6.33 Mn |